HIF-1α expression was recently correlated with radiotherapy response in breast cancer, oropharyngeal cancer [35], head and neck cancer [36], early esophageal cancer [37], and nasopharyngeal carcinomas [38] or cervical cancer [39]. This evidence concerns the gene HIF1A and oropharynx cancer.